Cite
HARVARD Citation
Kopylov, U. et al. (2017). Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience. Inflammatory bowel diseases. 23 (3), pp. 404-408. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kopylov, U. et al. (2017). Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience. Inflammatory bowel diseases. 23 (3), pp. 404-408. [Online].